Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Vaccines

  Free Subscription


11.05.2025

4 BMJ
1 J Infect
2 J Infect Dis
2 J Virol
3 JAMA
1 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
2 Pediatrics
1 PLoS Biol
10 PLoS One
1 Proc Natl Acad Sci U S A
21 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMJ

  1. WISE J
    Live shingles vaccine linked to lower risk of heart disease.
    BMJ. 2025;389:r949.
    PubMed        

  2. TANNE JH
    RFK Jr orders new vaccine testing and $500m universal vaccine programme, as measles cases rise.
    BMJ. 2025;389:r902.
    PubMed        

  3. O'DOWD A
    Moderna could be expelled from ABPI after breaching rules over covid vaccine trial.
    BMJ. 2025;389:r889.
    PubMed        

  4. SEMINO E
    Better communication about vaccines could tackle scepticism.
    BMJ. 2025;389:r865.
    PubMed        


    J Infect

  5. RIEDMANN U, Chalupka A, Richter L, Werber D, et al
    Underlying health biases in previously-infected SARS-CoV-2 vaccination recipients: a cohort study.
    J Infect. 2025 Apr 30:106497. doi: 10.1016/j.jinf.2025.106497.
    PubMed         Abstract available


    J Infect Dis

  6. ABDELKADER S, Jefferson AA
    Trust, A Key to Counter Vaccine Hesitancy.
    J Infect Dis. 2025 May 8:jiaf239. doi: 10.1093.
    PubMed        


  7. Correction to: Relative Effectiveness and Waning of a Third Dose of mRNA COVID-19 Vaccine in Medicare Beneficiaries Aged 65 Years and Older during the BA.1/BA.2 Omicron Period.
    J Infect Dis. 2025 May 6:jiaf137. doi: 10.1093.
    PubMed        


    J Virol

  8. KARTHIGEYAN KP, Connors M, Binuya CR, Gross M, et al
    A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice.
    J Virol. 2025 May 8:e0217824. doi: 10.1128/jvi.02178.
    PubMed         Abstract available

  9. LUGANO D, Mwangi K, Mware B, Kibet G, et al
    Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.
    J Virol. 2025 May 6:e0048225. doi: 10.1128/jvi.00482.
    PubMed         Abstract available


    JAMA

  10. KARABA AH, Segev DL, Werbel WA
    Respiratory Syncytial Virus Vaccination-Reply.
    JAMA. 2025 May 7. doi: 10.1001/jama.2025.2141.
    PubMed        

  11. VICENTE-RABANEDA EF, Cardenoso-Domingo L, Castaneda S
    Respiratory Syncytial Virus Vaccination.
    JAMA. 2025 May 7. doi: 10.1001/jama.2025.2137.
    PubMed        

  12. RUDMAN SPERGEL AK, Wu I, Deng W, Cardona J, et al
    Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults >/=50 Years: A Randomized Clinical Trial.
    JAMA. 2025 May 7:e255646. doi: 10.1001/jama.2025.5646.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  13. PATTON ME, Moline HL, Whitaker M, Tannis A, et al
    Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:273-281.
    PubMed         Abstract available


    N Engl J Med

  14. SCHMIDT AC, Fairlie L, Hellstrom E, Luabeya Kany Kany A, et al
    BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection.
    N Engl J Med. 2025;392:1789-1800.
    PubMed         Abstract available


    Pediatrics

  15. IRVING SA, Crane B, Weintraub ES, Patel SA, et al
    Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-2024.
    Pediatrics. 2025 May 6:e2024070240. doi: 10.1542/peds.2024-070240.
    PubMed         Abstract available

  16. HAYEK H, Gailani A, Halasa NB
    Barriers to Administering Maternal RSV Vaccination and Monoclonal Antibodies.
    Pediatrics. 2025 May 6:e2025070649. doi: 10.1542/peds.2025-070649.
    PubMed        


    PLoS Biol

  17. FERGUSON EA, Lugelo A, Czupryna A, Anderson D, et al
    Improved effectiveness of vaccination campaigns against rabies by reducing spatial heterogeneity in coverage.
    PLoS Biol. 2025;23:e3002872.
    PubMed         Abstract available


    PLoS One

  18. LI Y, Zhao IY, Lu W, Leung SF, et al
    Are people willing to take regular vaccinations? A qualitative study among diverse ethnic groups in Hong Kong.
    PLoS One. 2025;20:e0318631.
    PubMed         Abstract available

  19. MANTINA NM, Smith J, Miiro FN, Magrath PA, et al
    Perspectives of HPV vaccine decision-making among young adults: A qualitative systematic review and evidence synthesis.
    PLoS One. 2025;20:e0321448.
    PubMed         Abstract available

  20. SIM J, Smith LE, Amlot R, Rubin GJ, et al
    Discrimination of a single-item scale to measure intention to have a COVID-19 vaccine.
    PLoS One. 2025;20:e0322503.
    PubMed         Abstract available


  21. Retraction: An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV).
    PLoS One. 2025;20:e0324071.
    PubMed        


  22. Retraction: Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach.
    PLoS One. 2025;20:e0324076.
    PubMed        

  23. LAYTON JB, Lloyd PC, Peetluk LS, Jiao Y, et al
    Effectiveness over time of a primary series of the original monovalent COVID-19 vaccines in adults in the United States.
    PLoS One. 2025;20:e0320434.
    PubMed         Abstract available

  24. METKIE KA, Asgedom YS, Sertsewold SG, Abebe M, et al
    Polio vaccination and marginal effects among children aged 12-23 months in Lesotho using 2024 LDHS data: A multilevel analysis approach.
    PLoS One. 2025;20:e0322731.
    PubMed         Abstract available

  25. DE LA CRUZ HERRERA M, Fuster-Casanovas A, Miro Catalina Q, Cigarrran Mensa M, et al
    Use of virtual reality in the reduction of pain after the administration of vaccines among children in primary care centers in Central Catalonia: Randomized clinical trial.
    PLoS One. 2025;20:e0322840.
    PubMed         Abstract available


  26. Retraction: In Silico design of a multi-epitope vaccine for Human Parechovirus: Integrating immunoinformatics and computational techniques.
    PLoS One. 2025;20:e0324093.
    PubMed        

  27. MATHKOUR A, Alzahrani AH, Narapureddy BR, Alqahtani FM, et al
    Prevalence and risk factors of burnout among employees at COVID-19 vaccination centers: A cross-sectional study.
    PLoS One. 2025;20:e0322803.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  28. WINHEIM E, Santos-Peral A, Ehm T, Rinke L, et al
    Interferon-induced activation of dendritic cells and monocytes by yellow fever vaccination correlates with early antibody responses.
    Proc Natl Acad Sci U S A. 2025;122:e2422236122.
    PubMed         Abstract available


    Vaccine

  29. GEORGIADIS N, Katsimpris A, Tzanakaki G, Tsiodras S, et al
    Cross-protection of meningococcal B vaccines against gonorrhea: A systematic review and Meta-analysis.
    Vaccine. 2025;56:127180.
    PubMed         Abstract available

  30. MASHAMBA M, Msibi T, Tshabalala G, Tsotetsi L, et al
    Factors influencing influenza vaccine uptake among adults in Johannesburg, South Africa: A qualitative study.
    Vaccine. 2025;57:127133.
    PubMed         Abstract available

  31. RAHA JR, Kim KH, Le CTT, Bhatnagar N, et al
    Intranasal vaccination with multi-neuraminidase and M2e virus-like particle vaccine results in greater mucosal immunity and protection against influenza than intramuscular injection.
    Vaccine. 2025;57:127206.
    PubMed         Abstract available

  32. GUMASING MJJ
    Rebuilding Public Trust: Factors Influencing Dengue Vaccine Uptake in the Aftermath of the Dengvaxia Controversy in the Philippines: A Partial Least Structural Equation Modeling Approach.
    Vaccine. 2025;57:127220.
    PubMed         Abstract available

  33. VIETHS S, Waibler Z, Schumann GG
    Opting for the appropriate methodology for quantification of residual DNA impurities in mRNA vaccines.
    Vaccine. 2025;56:127186.
    PubMed        

  34. SZONDY I, Lorincz K, Walter A, Mohammed AA, et al
    Evaluating cross-protection: Meningococcal vaccines show effectiveness in gonorrhoea prevention - A systematic review and meta-analysis.
    Vaccine. 2025;56:127188.
    PubMed         Abstract available

  35. PADRON-REGALADO E, Escudero Gonzalez NA, Del Carmen Selvera HN
    Morbidity of viral vaccine preventable diseases in the Mexican states bordering the U.S., 2014-2023.
    Vaccine. 2025;56:127192.
    PubMed         Abstract available

  36. ASHRAF U, Lee A, Gao Q, Gonzalez JC, et al
    Impact of age and prior COVID-19 on the response to influenza a components in the 2020-2021 Fluzone vaccine.
    Vaccine. 2025;56:127171.
    PubMed         Abstract available

  37. BOUADDI O, Khalis M, Abdellatifi M, Seedat F, et al
    Behavioural and social drivers of vaccination among child and adult migrants in Morocco: A qualitative interview study.
    Vaccine. 2025;56:127166.
    PubMed         Abstract available

  38. PITTER JG, Mihajlovic J, Nagy D, van der Schans J, et al
    Underreported influenza mortality in Central and Eastern Europe hinders the extension of seasonal influenza vaccination programs in older adults.
    Vaccine. 2025;56:127184.
    PubMed         Abstract available

  39. ANNEQUIN M, Mora M, Fressard L, Cogordan C, et al
    The relationship between men who have sex with men on PrEP and care providers is essential for HPV vaccination: A mixed-methods study in France.
    Vaccine. 2025;56:127190.
    PubMed         Abstract available

  40. ALGREN MH, Timmermann A, Valentiner-Branth P, Thygesen LC, et al
    Comparing Risk Behaviour among 14,614 Human Papillomavirus Vaccinated and Unvaccinated Danish Young Women.
    Vaccine. 2025;56:127202.
    PubMed         Abstract available

  41. KANESHITA S, Chambers CD, Johnson D, Kavanaugh A, et al
    Short-term side effects following COVID-19 vaccination in pregnancies complicated by autoimmune inflammatory rheumatic diseases: A prospective cohort study.
    Vaccine. 2025;56:127194.
    PubMed         Abstract available

  42. BADZI CD, Modey E, Apreku A, Guure C, et al
    Factors influencing COVID-19 vaccine uptake among pregnant women in Greater Accra Region, Ghana.
    Vaccine. 2025 May 1:127073. doi: 10.1016/j.vaccine.2025.127073.
    PubMed         Abstract available

  43. AKMATOVA R, Otorbaeva D, Ebama MS
    Impact of the COVID-19 pandemic on influenza knowledge, attitudes, and vaccination practices in at-risk groups in the Kyrgyz Republic: A comparative study.
    Vaccine. 2025;56:127159.
    PubMed         Abstract available

  44. IBARZ-PAVON AB, Bielsky MC, Bose R, Cavaleri M, et al
    Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.
    Vaccine. 2025;56:127189.
    PubMed         Abstract available

  45. CHAN YT, Chair SY, Gao RT, Ng MH, et al
    Effect of vaccine education intervention on vaccine uptake and vaccine knowledge among older adults: A systematic review with meta-analysis.
    Vaccine. 2025;56:127182.
    PubMed         Abstract available

  46. OTORBAEVA D, Akmatova R, Cooley KM, Iwamoto C, et al
    Corrigendum to "Post-introduction evaluation (PIE) of the seasonal influenza vaccination program in Kyrgyzstan in 2023" Vaccine 55 (2025) 127052.
    Vaccine. 2025;56:127123.
    PubMed        

  47. WHELDRAKE K, Sisnowski J, AHoure M, Anagnostou N, et al
    Surveillance of adverse events following immunisation with meningococcal B vaccine (4CMenB), South Australia, 2018-2022.
    Vaccine. 2025;56:127158.
    PubMed         Abstract available

  48. ZHANG Z, Yildirim M, Keskinocak P, Dasthagirisaheb YBS, et al
    Serotype specific pneumococcal vaccine effectiveness in children with sickle cell disease: A two-decade analysis.
    Vaccine. 2025;56:127193.
    PubMed         Abstract available

  49. SEFAT KMSR, Kulkarni R, Trinh J, Leekha A, et al
    Mucosal vaccines with STING-agonist liposomal formulations inhibit RSV (respiratory syncytial virus) replication in cotton rats.
    Vaccine. 2025;56:127183.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.